Overview of the structure and function of the dopamine transporter and its protein interactions
Frontiers in Physiology · 03.03.2023 · 14
DOI: 10.3389/fphys.2023.1150355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 03.03.2023. Verfasst von Binod Nepal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The dopamine transporter (DAT) plays an integral role in dopamine neurotransmission through the clearance of dopamine from the extracellular space. Dysregulation of DAT is central to the pathophysiology of numerous neuropsychiatric disorders and as such is an attractive therapeutic target. DAT belongs to the solute carrier family 6 (SLC6) class of Na + /Cl − dependent transporters that move various cargo into neurons against their concentration gradient. This review focuses on DAT (SCL6A3 protein) while extending the narrative to the closely related transporters for serotonin and norepinephrine where needed for comparison or functional relevance. Cloning and site-directed mutagenesis experiments provided early structural knowledge of DAT but our contemporary understanding was achieved through a combination of crystallization of the related bacterial transporter LeuT, homology modeling, and subsequently the crystallization of drosophila DAT. These seminal findings enabled a better understanding of the conformational states involved in the transport of substrate, subsequently aiding state-specific drug design. Post-translational modifications to DAT such as phosphorylation, palmitoylation, ubiquitination also influence the plasma membrane localization and kinetics. Substrates and drugs can interact with multiple sites within DAT including the primary S1 and S2 sites involved in dopamine binding and novel allosteric sites. Major research has centered around the question what determines the substrate and inhibitor selectivity of DAT in comparison to serotonin and norepinephrine transporters. DAT has been implicated in many neurological disorders and may play a role in the pathology of HIV and Parkinson’s disease via direct physical interaction with HIV-1 Tat and α-synuclein proteins respectively.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
- Department of Psychiatry, New York University School of Medicine, New York City, NY, United States.
Zitieren
APA
Nepal, B., Das, S., Reith, M. E., & Kortagere, S. (2023). Overview of the structure and function of the dopamine transporter and its protein interactions. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1150355
Vancouver
Nepal B, Das S, Reith ME, Kortagere S. Overview of the structure and function of the dopamine transporter and its protein interactions. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1150355
BibTeX
@article{Nepal2023,
author = {Nepal, Binod and Das, Sanjay and Reith, Maarten E and Kortagere, Sandhya},
title = {Overview of the structure and function of the dopamine transporter and its protein interactions},
journal = {Frontiers in Physiology},
year = {2023},
volume = {14},
doi = {10.3389/fphys.2023.1150355}
}
EUVIMED